Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients

Endocrine

Volumn 38, Issue 2, 2010, Pages 266-275

  Chen, Lu Lu ^a   Liao, Yun Fei ^a   Zeng, Tian Shu ^a   Yu, Fan ^a   Li, Hui Qing ^a   Feng, Yong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Endothelial progenitor cell; Gliclazide; Metformin; Oxidative stress; Type 2 diabetes

Indexed keywords

GLICLAZIDE; LECTIN; LOW DENSITY LIPOPROTEIN; METFORMIN;

ADULT; ARTICLE; CELL COUNT; CELL FUNCTION; CELL MIGRATION; CLINICAL ARTICLE; COLONY FORMING UNIT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; LIPID TRANSPORT; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL; TREATMENT DURATION; UPREGULATION;

EID: 78149407646     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9383-8     Document Type: Article

References (35)

1. GP Fadini C Agostini A Avogaro 2005 Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives Curr. Diabetes Rev. 1 41 58 1:CAS:528:DC%2BD2MXitVeltro%3D 10.2174/ 1573399052952640 18220581
2. GP Fadini S Sartore C Agostini A Avogaro 2007 Significance of endothelial progenitor cells in subjects with diabetes Diabetes Care 30 1305 1313 1:CAS:528:DC%2BD2sXmtFKmsr0%3D 10.2337/dc06-2305 17277037 (Pubitemid 46684670)
3. GP Fadini M Miorin M Facco S Bonamico I Baesso F Grego M Menegolo SV de Kreutzenberg A Tiengo C Agostini A Avogaro 2005 Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus J. Am. Coll. Cardiol. 45 1449 1457 1:CAS:528: DC%2BD2MXjvVKku7k%3D 10.1016/j.jacc.2004.11.067 15862417 (Pubitemid 40615617)
4. OM Tepper RD Galiano JM Capla C Kalka PJ Gagne GR Jacobowitz JP Levine GC Gurtner 2002 Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures Circulation 106 2781 2786 10.1161/01.CIR.0000039526.42991.93 12451003 (Pubitemid 35396976)
5. GP Fadini S Sartore M Albiero I Baesso E Murphy M Menegolo F Grego S Vigili de Kreutzenberg A Tiengo C Agostini A Avogaro 2006 Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy Arterioscler. Thromb. Vasc. Biol. 26 2140 2146 1:CAS:528:DC%2BD28XotVWltbY%3D 10.1161/01.ATV.0000237750.44469.88 16857948 (Pubitemid 44253800)
6. DP Macfarlane KR Paterson M Fisher 2007 Oral antidiabetic agents as cardiovascular drugs Diabetes Obes. Metab. 9 23 30 1:CAS:528: DC%2BD2sXitlCgsL0%3D 10.1111/j.1463-1326.2006.00592.x 17199715 (Pubitemid 44921038)
7. Y Sahin K Unluhizarci A Yilmazsoy A Yikilmaz E Aygen F Kelestimur 2007 The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome Clin. Endocrinol. (Oxf) 67 904 908 1:CAS:528:DC%2BD1cXitVyluw%3D%3D 10.1111/j.1365-2265.2007.02985.x (Pubitemid 350135135)
8. UK Prospective Diabetes Study UKPDS Group 1998 Effect of intensive blood glucose control with metformin on complications in overnight patients with type 2 diabetes (UKPDS 34) Lancet 352 854 865 10.1016/S0140-6736(98)07037-8 (Pubitemid 28416719)
9. ADVANCE Collaborative Group A Patel S MacMahon J Chalmers B Neal L Billot M Woodward M Marre M Cooper P Glasziou D Grobbee P Hamet S Harrap S Heller L Liu G Mancia CE Mogensen C Pan N Poulter A Rodgers B Williams S Bompoint BE de Galan R Joshi F Travert 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N. Engl. J. Med. 358 2560 2572 1:CAS:528:DC%2BD1cXnt1yht7s%3D 10.1056/NEJMicm066227 18539916 (Pubitemid 351214289)
10. American Diabetes Association 2008 Standards of Medical Care in Diabetes-2008 Diabetes Care 31 S12 54S 10.2337/dc08-S012 (Pubitemid 351520688)
11. M Brownlee 2005 The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 1615 1625 1:CAS:528:DC%2BD2MXltVaisbk%3D 10.2337/diabetes.54.6.1615 15919781 (Pubitemid 40770750)
12. J Haendeler S Dimmeler 2006 Inseparably tied: functional and antioxidative capacity of endothelial progenitor cells Circ. Res. 98 157 158 1:CAS:528:DC%2BD28XitF2itLk%3D 10.1161/01.RES.0000204552.28409.a2 16456104
13. G Formoso EA De Filippis N Michetti P Di Fulvio A Pandolfi T Bucciarelli G Ciabattoni A Nicolucci G Davì A Consoli 2008 Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects Diabetes Metab. Res. Rev. 24 231 237 1:CAS:528:DC%2BD1cXks1Sgs7k%3D 10.1002/dmrr.794 17966969 (Pubitemid 351385541)
14. CM Sena T Louro P Matafome E Nunes P Monteiro R Seiça 2009 Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high fat diet Physiol. Res. 58 203 209 1:CAS:528:DC%2BD1MXlslOisb8%3D 18380531
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197 (1997)
16. JM Hill G Zalos JP Halcox WH Schenke MA Waclawiw AA Quyyumi T Finkel 2003 Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N. Engl. J. Med. 348 593 600 10.1056/NEJMoa022287 12584367 (Pubitemid 36204953)
17. W Kim MH Jeong SH Cho JH Yun HJ Chae YK Ahn MC Lee X Cheng T Kondo T Murohara JC Kang 2006 Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers Circ. J 70 1052 1057 1:CAS:528:DC%2BD28XoslKgtL4%3D 10.1253/circj.70.1052 16864941 (Pubitemid 44161745)
18. Y Numaguchi T Sone K Okumura M Ishii Y Morita R Kubota K Yokouchi H Imai M Harada H Osanai T Kondo T Murohara 2006 The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction Circulation 114 I114 I119 10.1161/CIRCULATIONAHA.105.000588 16820559 (Pubitemid 44297138)
19. C Murphy GS Kanaganayagam B Jiang PJ Chowienczyk R Zbinden M Saha S Rahman AM Shah MS Marber MT Kearney 2007 Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK south Asian men Arterioscler. Thromb. Vasc. Biol. 27 936 942 1:CAS:528:DC%2BD2sXislCrsrw%3D 10.1161/01.ATV.0000258788.11372.d0 17255539 (Pubitemid 46606728)
20. N Werner S Kosiol T Schiegl P Ahlers K Walenta A Link M Böhm G Nickenig 2005 Circulating endothelial progenitor cells and cardiovascular outcomes N. Engl. J. Med. 353 999 1007 1:CAS:528:DC%2BD2MXpvVOisbw%3D 10.1056/NEJMoa043814 16148285 (Pubitemid 41262334)
21. S Rafii D Lyden 2003 Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat. Med. 9 702 712 1:CAS:528:DC%2BD3sXktFOnuro%3D 10.1038/nm0603-702 12778169 (Pubitemid 36749219)
22. J Kao J Tobis RL McClelland MR Heaton BR Davis DR Holmes JW Currier 2004 Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention Am. J. Cardiol. 93 1347 1350 1:CAS:528:DC%2BD2cXksVGgsrg%3D 10.1016/j.amjcard.2004.02.028 15165912 (Pubitemid 38692459)
23. JA Johnson SR Majumdar SH Simpson EL Toth 2002 Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes Diabetes Care 25 2244 2248 1:CAS:528:DC%2BD38Xps1Kks7s%3D 10.2337/diacare.25.12.2244 12453968 (Pubitemid 41071035)
24. M Gulliford R Latinovic 2004 Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study Diabetes Metab. Res. Rev. 20 239 245 1:CAS:528:DC%2BD2cXltFOlu7k%3D 10.1002/dmrr.457 15133756 (Pubitemid 38714323)
25. KH Kahler M Rajan GG Rhoads MM Safford K Demissie SE Lu 2007 Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the veterans health administration Diabetes Care 30 1689 1693 1:CAS:528:DC%2BD2sXotlWhsLY%3D 10.2337/dc06-2272 17440170 (Pubitemid 47036337)
26. JM Evans SA Ogston A Emslie-Smith AD Morris 2006 Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin Diabetologia 49 930 936 1:CAS:528:DC%2BD28XjvFWrt7o%3D 10.1007/s00125-006-0176-9 16525843
27. C Werner CH Kamani C Gensch M Böhm U Laufs 2007 The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance Diabetes 56 2609 2615 1:CAS:528: DC%2BD2sXhtFygt73J 10.2337/db07-0069 17623816 (Pubitemid 47523269)
28. M Hristov C Fach C Becker N Heussen EA Liehn R Blindt P Hanrath C Weber 2007 Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment Atherosclerosis 192 413 420 1:CAS:528:DC%2BD2sXls1ahur4%3D 10.1016/j. atherosclerosis.2006.05.031 16837000 (Pubitemid 46726323)
29. RR Holman SK Paul MA Bethel DR Matthews HA Neil 2008 10-year follow-up of intensive glucose control in type 2 diabetes N. Engl. J. Med. 359 1577 1589 1:CAS:528:DC%2BD1cXht1Wgt7nK 10.1056/NEJMoa0806470 18784090
30. T Thum D Fraccarollo M Schultheiss S Froese P Galuppo JD Widder D Tsikas G Ertl J Bauersachs 2007 Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes Diabetes 56 666 674 1:CAS:528:DC%2BD2sXis12it70%3D 10.2337/db06-0699 17327434 (Pubitemid 46348461)
31. YH Chen SJ Lin FY Lin TC Wu CR Tsao PH Huang PL Liu YL Chen JW Chen 2007 High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms Diabetes 56 1559 1568 1:CAS:528:DC%2BD2sXmtlKhsrw%3D 10.2337/db06-1103 17389326 (Pubitemid 46842612)
32. G Zhou R Myers Y Li Y Chen X Shen J Fenyk-Melody M Wu J Ventre T Doebber N Fujii N Musi MF Hirshman LJ Goodyear DE Moller 2001 Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 1167 1174 1:CAS:528:DC%2BD3MXns1ChsL4%3D 11602624
33. N Musi MF Hirshman J Nygren M Svanfeldt P Bavenholm O Rooyackers G Zhou JM Williamson O Ljunqvist S Efendic DE Moller A Thorell LJ Goodyear 2002 Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes Diabetes 51 2074 2081 1:CAS:528: DC%2BD38Xlt1WltrY%3D 10.2337/diabetes.51.7.2074 12086935
34. PE Jennings 2000 Vascular benefits of gliclazide beyond glycemic control Metabolism 49 17 20 1:CAS:528:DC%2BD3cXnsFOmtbc%3D 10.1053/meta.2000.17825 11078471
35. K. Ukinc, S. Eminagaoglu, H.O. Ersoz, C. Erem, C. Karahan, A.B. Hacihasanoglu, M. Kocak, A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 26, (2009) [Epub ahead of print]